MDLN · Company research
Medline Inc. Class A common stock (MDLN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
25records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| GIC Private Ltd sells $274.8 million in Medline (MDLN) shares - Investing.com | GIC Private Ltd sells $274.8 million in Medline (MDLN) shares Investing.com | View source ↗ | Investing.com | Oct 17, 2026 | neutral | 0 | 0.6 |
| Medline $MDLN Stock Acquired by Banque Pictet & Cie SA - MarketBeat | Medline $MDLN Stock Acquired by Banque Pictet & Cie SA MarketBeat | View source ↗ | MarketBeat | Oct 17, 2026 | neutral | 0 | 0.6 |
| Medline Inc.: Beware The Private Equity Overhang (NASDAQ:MDLN) - Seeking Alpha | Medline Inc.: Beware The Private Equity Overhang (NASDAQ:MDLN) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 16, 2026 | neutral | 0 | 0.6 |
| MDLN Oct 2026 20.000 call (MDLN261016C00020000) Interactive Stock Chart - Yahoo! Finance Canada | MDLN Oct 2026 20.000 call (MDLN261016C00020000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| A new medical supply center near Detroit is expected to bring local jobs - Stock Titan | A new medical supply center near Detroit is expected to bring local jobs Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Medline (NASDAQ:MDLN) Stock Has Average Target Price of $46.81 - MarketBeat | Medline (NASDAQ:MDLN) Stock Has Average Target Price of $46.81 MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN | Pomerantz LLP is investigating Medline Inc. for potential securities fraud following an FDA warning letter in June 2026 detailing significant manufacturing violations. The company's stock fell 7.16% on the FDA announcement and an additional 12.79% in August when Medline disclosed that remediation efforts resulted in earnings losses. | View source ↗ | GlobeNewswire Inc. | Oct 13, 2026 | bearish | -1 | 1 |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN | Pomerantz LLP is investigating Medline Inc. for potential securities fraud following an FDA warning letter in June 2026 detailing significant manufacturing violations. The company's stock fell 7.16% on the FDA announcement and an additional 12.79% in August when Medline disclosed that remediation efforts resulted in earnings losses. | View source ↗ | GlobeNewswire Inc. | Oct 13, 2026 | bearish | -1 | 1 |
| A 10% owner sells Medline (MDLN) shares; the reported indirect position afterward is 69.4M shares. - Stock Titan | A 10% owner sells Medline (MDLN) shares; the reported indirect position afterward is 69.4M shares. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Medline (MDLN) Faces Fraud Probe After 13% Stock Drop - TradingView | Medline (MDLN) Faces Fraud Probe After 13% Stock Drop TradingView | View source ↗ | TradingView | Oct 13, 2026 | neutral | 0 | 0.6 |
| Lobbying Update: $80,000 of MEDLINE lobbying was just disclosed - Quiver Quantitative | Lobbying Update: $80,000 of MEDLINE lobbying was just disclosed Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 12, 2026 | neutral | 0 | 0.6 |
| (MDLN) Movement as an Input in Quant Signal Sets - Stock Traders Daily | (MDLN) Movement as an Input in Quant Signal Sets Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,570,999 Shares - MarketBeat | Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,570,999 Shares MarketBeat | View source ↗ | MarketBeat | Oct 7, 2026 | neutral | 0 | 0.6 |
| Medline (NasdaqGS:MDLN) Stock Forecast & Analyst Predictions - Simply Wall Street | Medline (NasdaqGS:MDLN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 7, 2026 | neutral | 0 | 0.6 |
| Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,088,987 Shares - MarketBeat | Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,088,987 Shares MarketBeat | View source ↗ | MarketBeat | Oct 7, 2026 | neutral | 0 | 0.6 |
| 10% owners sell Medline (MDLN) shares in five transactions across three dates. - Stock Titan | 10% owners sell Medline (MDLN) shares in five transactions across three dates. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway - PR Newswire | MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway PR Newswire | View source ↗ | PR Newswire | Oct 6, 2026 | neutral | 0 | 0.6 |
| Medline (MDLN) Faces Securities Fraud Probe After 13% Stock Drop - TradingView | Medline (MDLN) Faces Securities Fraud Probe After 13% Stock Drop TradingView | View source ↗ | TradingView | Oct 6, 2026 | neutral | 0 | 0.6 |
| Bragar Eagel & Squire, P.C. is Investigating Medline Inc. on Behalf of Medline Stockholders and Encourages Investors to Contact the Firm | Law firm Bragar Eagel & Squire is investigating Medline Inc. for potential securities law violations following FDA warning letters regarding manufacturing practice violations. The company's stock declined 7.2% on June 2, 2026 after FDA warnings and another 12.8% on August 5, 2026 after the company disclosed earnings losses from remediation efforts including product recalls. | View source ↗ | GlobeNewswire Inc. | Oct 1, 2026 | bearish | -1 | 1 |
| Bragar Eagel & Squire, P.C. is Investigating Medline Inc. on Behalf of Medline Stockholders and Encourages Investors to Contact the Firm | Law firm Bragar Eagel & Squire is investigating Medline Inc. for potential securities law violations following FDA warning letters regarding manufacturing practice violations. The company's stock declined 7.2% on June 2, 2026 after FDA warnings and another 12.8% on August 5, 2026 after the company disclosed earnings losses from remediation efforts including product recalls. | View source ↗ | GlobeNewswire Inc. | Oct 1, 2026 | bearish | -1 | 1 |
| Medline (MDLN) Stock Could Trade Below Fair Value As Shares Fell 22% - Yahoo Finance | Medline (MDLN) Stock Could Trade Below Fair Value As Shares Fell 22% Yahoo Finance | View source ↗ | Yahoo Finance | Sep 19, 2026 | neutral | 0 | 0.6 |
| MDLN Stock Price and Chart — NASDAQ:MDLN - TradingView | MDLN Stock Price and Chart — NASDAQ:MDLN TradingView | View source ↗ | TradingView | Aug 23, 2026 | neutral | 0 | 0.6 |
| Why Medline (MDLN) Stock Is Up Today - Quiver Quantitative | Why Medline (MDLN) Stock Is Up Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 21, 2026 | neutral | 0 | 0.6 |
| Medline (MDLN) Stock Faces Margin Strain Despite Double Digit Revenue Growth - Simply Wall Street | Medline (MDLN) Stock Faces Margin Strain Despite Double Digit Revenue Growth Simply Wall Street | View source ↗ | Simply Wall Street | Aug 5, 2026 | neutral | 0 | 0.6 |
| Is Medline Inc. (MDLN) A Good Stock To Buy Now? - Yahoo Finance | Is Medline Inc. (MDLN) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 6, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.